KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Equity Income (2017 - 2025)

Historic Equity Income for Astrana Health (ASTH) over the last 9 years, with Q3 2025 value amounting to $1.0 million.

  • Astrana Health's Equity Income fell 2721.43% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 6112.04%. This contributed to the annual value of $4.5 million for FY2024, which is 2021.87% down from last year.
  • Latest data reveals that Astrana Health reported Equity Income of $1.0 million as of Q3 2025, which was down 2721.43% from $400000.0 recorded in Q2 2025.
  • Astrana Health's Equity Income's 5-year high stood at $2.7 million during Q2 2023, with a 5-year trough of -$3.1 million in Q2 2021.
  • Over the past 5 years, Astrana Health's median Equity Income value was $1.2 million (recorded in 2022), while the average stood at $736473.7.
  • Examining YoY changes over the last 5 years, Astrana Health's Equity Income showed a top increase of 44416.87% in 2021 and a maximum decrease of 47577.94% in 2021.
  • Quarter analysis of 5 years shows Astrana Health's Equity Income stood at -$626000.0 in 2021, then skyrocketed by 295.69% to $1.2 million in 2022, then skyrocketed by 102.04% to $2.5 million in 2023, then plummeted by 37.33% to $1.6 million in 2024, then crashed by 34.3% to $1.0 million in 2025.
  • Its Equity Income was $1.0 million in Q3 2025, compared to $400000.0 in Q2 2025 and -$867000.0 in Q1 2025.